Active Acne and Infection Risk Before Facial Injectables

· 6 min read

Editorial illustration of active acne and infection risk in HOF

Quick facts

What is the concern
Inflamed lesions, pustules and cysts concentrate bacteria on the skin; crossing that skin with a needle or cannula can carry microorganisms into deeper planes.
Usual approach
Avoid injecting over or through active lesions and, when the picture is in an extensive inflammatory phase, postpone and treat first, at the professional's discretion.
What not to confuse
Mild, scarring or comedonal acne outside the puncture area is read differently from inflamed nodulocystic acne.
Essential record
Skin condition on the day, decision made, reason and instructions given to the patient.

Every practitioner has had the appointment in which the patient arrives with an acne flare-up, booked weeks ago, "just for a touch-up." The practical question is where the skin is the barrier protecting the deep tissue, and whether it is worth crossing it that day. This guide brings together the risk reasoning, the logic of postponing or proceeding and the communication with the patient, at a review level. Specific approaches, medications and timeframes are decisions for the licensed professional, according to the rules of their professional council in Brazil.

Why does active acne change the infection risk?

Acne vulgaris is an inflammatory disease of the pilosebaceous follicle, with bacterial colonization, sebum production and an inflammatory response. The skin barrier around pustules, nodules and cysts is altered, and the microbial load there is higher than in healthy skin.

In injectable procedures, the needle or cannula crosses that barrier. If the puncture point is a lesion, or sits over inflamed skin, there is a chance of carrying microorganisms into deeper layers, where a hyaluronic acid gel can serve as a substrate for biofilm. That is the underlying logic of the caution, with no need for numbers.

The risk is not the same for every product. Fillers and biostimulators leave material in the tissue, which increases the weight of contamination. Botulinum toxin, since it leaves no volume, has a different profile, although puncturing infected skin is still a bad idea.

What to assess in the skin before deciding

Examine the skin under good light, from the front and from the side, and answer simple questions.

This exam is part of the medical history and of the day of the procedure. The relationship with herpes is discussed in cold sores and filler.

When to proceed, adjust or postpone?

There is no universal table, but a decision logic helps standardize the clinic's approach.

Skin situation Reading Usual direction (at the professional's discretion)
Mild acne, comedones, no inflammation in the area Low local risk May proceed, with rigorous asepsis
Inflamed pustule or papule far from the puncture point Localized risk Avoid the lesion; evaluate the plan carefully
Inflamed lesions in the area to be treated Increased risk Postpone the area or the procedure
Extensive active nodulocystic acne Inflammatory picture Postpone and prioritize acne treatment
Signs of secondary infection Infection Do not inject; treat and reassess
Acne scars without active inflammation Not a contraindication by itself May proceed; assess the goal

Asepsis and biosafety in these cases

Asepsis is essential in every patient, but with acne it needs to be an impeccable routine:

  1. Skin cleansing per the clinic's protocol, without rubbing inflamed lesions.
  2. Appropriate gloves and field, with materials changed for each patient.
  3. Antisepsis of the area and care not to touch the already cleaned region.
  4. Safe disposal of sharps.

The general protocol is in biosafety in HOF, and the reasoning on late infections in infection and biofilm after filler and abscess after filler.

Does acne medication change the decision?

Yes, in some cases. Patients being treated for acne may use topical or oral medications that alter the skin, healing or bleeding. The most discussed is isotretinoin, which has its own page: isotretinoin and injectable procedures. Oral antibiotics, topical retinoids and other agents also belong in the medical history, and the correct practice is to ask, record and, when necessary, talk to the prescriber.

Another point: active acne often coexists with post-inflammatory hyperpigmentation. Puncturing reactive skin can increase the risk of marks in higher phototypes, one more reason to choose the timing well.

How to talk to the patient who wants to go ahead anyway

The patient often has an event scheduled and sees postponement as a loss. A clear conversation usually settles it:

Avoid promising a rescheduling date. Skin stabilization varies. If the patient insists, the clinical limit is still yours. The reasoning for saying no is in how to say no to the patient in HOF.

Documentation and consent

What is worth recording at every visit with acne:

  • an objective description of the lesions (type, location, approximate number);
  • the decision made (proceed, adjust, postpone) and the reason;
  • instructions given, including warning signs;
  • medications in use, with dates;
  • updated consent, naming infection as a risk.

See the general flow in patient records and documentation in HOF and the situations in which the approach is to stop, in general contraindications in HOF. The informed consent must list infection among the possible complications.

Where Harmy comes in

Frequent mistakes with active acne

  1. Injecting "around" the lesion without assessing the distance. A pustule close to the puncture point is still a source of microorganisms, and the surrounding skin is usually inflamed.
  2. Treating acne as a detail of the medical history. Asking only "do you have any allergies?" lets the flare-up, the medication in use and the picking of lesions slip by.
  3. Giving in to the patient's insistence. The event date is the patient's, but skin safety is your responsibility.
  4. Not photographing the skin condition. Without a record, it is hard to defend the decision to postpone or, in case of infection, to reconstruct the course.
  5. Forgetting the instruction not to touch. Squeezing lesions after the procedure increases the risk of contaminating the treated area.

What to advise after the procedure for someone with acne

  • Do not pick, rub or squeeze the treated area.
  • Keep up skin hygiene with gentle products, as instructed.
  • Avoid makeup or new products over the puncture points in the first hours, per the clinic's protocol.
  • Contact the practice for increasing pain, warmth, spreading redness or discharge.

Reinforce it in writing, together with the post-procedure instructions, because patients with acne tend to touch their skin out of habit.

Frequently asked questions

Can I do filler with active acne?

In general, injecting over inflamed lesions or pustules is avoided, and extensive inflammatory pictures usually justify postponing. The decision is the professional's, after examining the skin and the area to be treated.

Does active acne rule out botulinum toxin?

Not necessarily. The risk depends on where the lesions are in relation to the injection area. With lesions at the puncture points, the tendency is to postpone or adjust the plan, at the professional's discretion.

How long should I wait after treating acne?

There is no single timeframe. It is usual to wait for the inflammatory phase to settle and the skin to stabilize, and the interval is set by the professional following the case, according to severity and the treatment in use.

Can someone on isotretinoin have injectables?

It is a separate topic, with its own approach and discussion of intervals. See the dedicated page and decide with the prescriber and the assessment of the case, according to the rules of your professional council.

Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.

Terms mentioned